Drug hobbles deadly liver cancer by stifling protein production

(University of California - San Francisco) In laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach. Traditionally, targeted cancer therapies aim to disable proteins borne of cancer-driving genes. Instead, the UCSF scientists prevented these proteins, including those that shield tumors from the immune system, from being built in the first place.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news